London: The University of Oxford said on Friday that its researchers have begun recruiting adults and children for advanced human trials of a COVID-19 vaccine that will involve up to 10,260 volunteers across the UK. The initial human trials which began in April involved more than 1,000 volunteers. The immunisations in the initial trials have […]
New Delhi: The Indian Council of Medical Research on Monday said that India developed an Intelligent Testing Strategy to remain ‘ahead of the virus’ by developing testing infrastructure that is laboratories and other means of testing. According to ICMR, the country now has a capacity of testing 2 lakh samples per day. “India now has […]
London: Pharmaceutical giant GlaxoSmithKline on Thursday said it plans to produce 1 billion doses of coronavirus vaccine adjuvant, an ingredient that makes vaccines work better, in 2021 to support multiple Covid-19 vaccine collaborations. Saying that it has started manufacture of the adjuvant at risk, the company added that it was in discussions with governments and […]
Mumbai: In a major development, the Haj Committee of India (HCI) has said that no Indian Muslims shall be allowed to go for the annual Haj pilgrimage unless they have…
New York: Global pharmaceutical major Pfizer believes that a Covid-19 vaccine could be ready by the end of October, the company’s CEO Albert Bourla said. Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech. Bourla made the comments while […]
New Delhi: Swedens chief epidemiologist Dr Anders Tegnell said Covid-19 vaccine may be developed in 2020, but its production will only start by the end of 2021. In a webinar organized by Public Health Foundation of India, Tegnell, who is also the architect of Covid-19 Sweden’s lockdown-lite, said: “To reach full herd immunity to stop […]
Bhubaneswar: The Odisha government on Thursday demanded at least 25 lakh doses of COVID-19 vaccine in a single lot from the Centre as it is unable to expedite the ongoing…
London: AstraZeneca’s Covid-19 vaccine candidate developed by researchers from Oxford University will likely provide protection against the disease for one year, the British drug maker’s CEO told Belgian radio station Bel RTL on Tuesday. According to a report in City A.M., AstraZeneca is aiming to deliver two billion doses of the drug by the end […]
Mumbai: Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate Covid-19 cases after it received the Indian drug regulator’s approval. It will be available under the brand name FabiFlu as a prescription-based medication for Rs 103 per tablet, with a recommended dose of 1,800 mg twice a day on day 1 and […]
Mohali: After innovative products like safety devices, sanitizers and masks to fight COVID epidemic, the National Institutes of Pharmaceutical Education and Research (NIPERs) have now come up with an immunity booster Herbal Tea to strengthen physical resistance against the disease which has claimed more than 4.7 lakh people across the globe. As no new effective […]
Geneva: After admitting that the world may have a Covid-19 vaccine within one year or even a few months earlier, the World Health Organization (WHO) on Friday said that UK-based AstraZeneca is leading the vaccine race while US-based pharmaceutical major Moderan is not far behind. WHO Chief Scientist Soumya Swaminathan stated that the AstraZeneca’s coronavirus […]
New Delhi: Dexamethasone, an inexpensive and widely used steroid, was included in the treatment protocol for COVID-19 patients in moderate to severe stages of illness by the Union health ministry on Saturday. The updated ‘Clinical Management Protocols for COVID-19’ advises the use of dexamethasone, which is already used in a wide range of conditions for […]
Hyderabad: Bharat Biotech, has successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level […]
New Delhi: Volunteers have begun participating in Brazil’s first clinical trial of Oxford COVID-19 vaccine. The ChAdOx1 vaccine technology is based on an adenovirus, and it is considered very safe, even in people with a weak immune system. The vaccine being used in the Brazilian trial, on 5,000 volunteers, is similar to the one used […]
New Delhi: After Bharat Biotech’s Covaxin, another potential COVID-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got nod from the Drugs Controller General of India (DCGI) on Thursday for human clinical trials, government sources said. The approval process was fast-tracked following a recommendation by the subject expert committee on COVID-19, considering the emergency […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.